Skip to main
PRA
PRA logo

ProAssurance (PRA) Stock Forecast & Price Target

ProAssurance (PRA) Analyst Ratings

Based on 3 analyst ratings
Hold
Strong Buy 0%
Buy 33%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

ProAssurance Corp has demonstrated a notable increase in net investment income, reporting a rise of 9.0% to $37.0 million compared to $33.9 million in the prior year, which reflects a strong performance that surpassed both internal estimates and consensus expectations. The company's top-line results exceeded expectations, supported by stable premiums within its medical malpractice segment, a key driver of revenue. Despite experiencing declines in other lines of business, the stability in the medical malpractice segment provides a solid foundation for future financial performance, contributing to a positive outlook for ProAssurance's stock.

Bears say

ProAssurance Corp experienced a decline in net premiums written, reporting a decrease of 2.3% to $276.1 million, which fell short of both internal estimates of $282.7 million and the consensus forecast of $279.9 million. This reduction marks a continuation of disappointing revenue performance compared to the previous year’s $282.7 million. Additionally, the underwriting results were significantly worse than expected, further contributing to a negative outlook for the company's financial future.

ProAssurance (PRA) has been analyzed by 3 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 33% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ProAssurance and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ProAssurance (PRA) Forecast

Analysts have given ProAssurance (PRA) a Hold based on their latest research and market trends.

According to 3 analysts, ProAssurance (PRA) has a Hold consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ProAssurance (PRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.